Joining a Crowding Market, ST and Second IVD Ally Plan to Launch Flu Chip in the Fall | GenomeWeb

Less than nine months after naming its first diagnostic partner, Swiss semiconductor company-turned-biochip start up ST Microelectronics said it plans to release a second IVD on its In-Check platform by the end of this year.

The company said last week in a statement that it is now working with Singapore-based Veredus Laboratories to release a rapid biochip-based test panel for influenza that will include strains of influenza H5N1, or bird flu, and allow users to identify strains of the virus in one hour.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.